Semnur Pharmaceuticals, Inc. is a venture backed specialty pharmaceutical start-up focused on the clinical and commercial development of innovative prescription products that meet the needs of pain management practitioners and their patients.
Our primary focus lies in the development of non-opioid prescription products for meeting the needs of patients with chronic back pain. This market comprises over 10 million patients in the US alone and over 50 million worldwide. We believe we have the technology to improve products` efficacy and safety and make a critical difference in the treatment of back pain patients. Currently there are inadequate treatments for chronic back pain patients globally and no currently approved treatments or surgery are curative. About 9 out of 10 adults will experience chronic back pain at some time in their lives. Back pain is the main cause of worker absenteeism and lost productivity in the USA.
In the United States, Semnur Pharma Inc. is planning to develop and commercialize its prescription products, either through its own efforts or in conjunction with partners. Outside of the United States, Semnur anticipates commercializing these products on a worldwide basis through select regional partnerships.